About Brian Helfand, MD
Brian T. Helfand, MD, a urologist at Endeavor Health, specializes in urologic oncology and the treatment of prostate conditions. His clinical expertise includes minimally invasive surgery, advanced laparoscopy and procedures using the da Vinci robotic system. Dr. Helfand treats conditions such as benign prostatic hyperplasia, prostate cancer and urinary dysfunction using personalized and evidence-based approaches.
My endeavor
My endeavor is to deliver the most advanced and personalized care for patients with prostate conditions, ensuring the right treatment is given to the right patient at the right time.
Care philosophy
I am committed to understanding each patient deeply and delivering passionate, personalized care that also integrates the latest technologies and cutting-edge research.
Overview
- Gender Male
- Personal interests Marathon running, Family, Traveling
Conditions treated (2)
- Prostate cancer
- Benign prostate hyperlasia
Procedures performed (4)
- Robotic assisted laparoscopic radical prostatectomy
- Aquablation (robotic assisted waterjet ablation of prostate)
- Minimal invasive and focal therapies for prostate cancer
- Minimal invasive therapies for BPH
Treatments offered (4)
- Robotic assisted laparoscopic radical prostatectomy
- Aquablation (robotic assisted waterjet ablation of prostate)
- Minimal invasive and focal therapies for prostate cancer
- Minimal invasive therapies for BPH
-
Endeavor Health Medical Group
2180 Pfingsten Rd., Suite 3000 Glenview, IL 60026-1340
-
2005Northwestern Feinberg School of Medicine
-
2011General SurgeryMcGaw Medical Center of Northwestern University
-
2012Urologic OncologyNorthwestern Feinberg School of Medicine
-
2014UrologyAmerican Board of Urology
-
Clinical Professor, The University of Chicago Pritzker School of Medicine
Pharmaceutical, device, and biotechnology companies frequently collaborate with research scientists and physicians to help advance scientific knowledge and improve patient care. These relationships can support scientific breakthroughs and help establish the effectiveness and safety of promising new therapies.
To ensure objectivity in clinical research and patient care, Endeavor Health maintains integrity policies requiring researchers and clinicians — whether in full-time, part-time and unpaid or voluntary roles — to disclose compensated and uncompensated relationships with external industry organizations.
Patients are encouraged to discuss these relationships with their physician as well as to inquire as to how these relationships are overseen by Endeavor Health. Learn more about our Conflict of Interest and Commitment Policy.
Additionally, patients can visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website, a national disclosure program that promotes a more transparent and accountable healthcare system. It houses a publicly accessible database of payments that reporting entities — including pharmaceutical, device, and biotechnology companies — make to covered recipients such as physicians and hospitals.
CMS is required by law to publish this data annually on or before June 30 for the previous reporting year. The data is published annually, so it may not reflect the most recent reporting period. If you have questions about the information, talk with your physician.
More about Brian

